NBTX 7.04 (+0.57%)
US63009J1079BiotechnologyBiotechnology

Nanobiotix (NBTX) Stock Highlights

7.04 | +0.57%
2024-06-03 03:11:17
Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Statistics

Range Today
7.04 7.16
Volume Today 1.1K
Range 1 Year
4.55 11
Volume 1 Year 19.55M
Range 3 Year
1.75 18
Volume 3 Year 64.61M
Range 10 Year
1.75 21.55
Volume 10 Year 67.17M

Highlights

Market Capitalization 331.66M (small)
Floating Shares 22.79M
Current Price 7.04
Price To Earnings -6.04
Price To Revenue 8.48
Earnings Per Share -1.17
Payout Ratio 0%

Performance

Latest +0.57%
1 Month +20.34%
3 Months +8.98%
6 Months +27.77%
1 Year +51.4%
3 Years -59.77%
5 Years -61.21%
10 Years -61.21%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.